adamantane has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britton, DR; DeNinno, MP; Jenner, P; Kebabian, JW; Perner, R; Schoenleber, R; Smith, L; Williams, M | 1 |
| Bédard, PJ; Blanchet, PJ; Britton, DR; Grondin, R; Shiosaki, K | 1 |
| Britton, DR; Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Shiosaki, K | 1 |
| Bédard, PJ; Di Paolo, T; Falardeau, P; Goulet, M; Grondin, R; Morissette, M; Rostène, W | 1 |
| Jenner, P; Smith, LA; Treseder, SA | 1 |
| Al-Barghouthy, G; Jackson, MJ; Jenner, P; Smith, LA | 1 |
| Kapitsa, IG; Kovalev, GI; Voronina, TA; Zimin, IA | 1 |
| Antipova, TA; Kovalev, GI; Logvinov, IO; Zimin, IA | 1 |
| Kovalev, GI; Salimov, RM | 1 |
| Ivanova, EA; Kapitsa, IG; Nepoklonov, AV; Val'dman, EA; Voronina, TA | 1 |
| Cao, X; Gao, T; Li, X; Lin, L; Liu, S; Luo, P; Qin, X; Sun, A; Wang, X; Wu, Q; Zhu, X | 1 |
11 other study(ies) available for adamantane and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adamantane; Administration, Oral; Animals; Antiparkinson Agents; Benzazepines; Benzopyrans; Binding Sites; Callithrix; Cell Line; Dopamine Agents; Fishes; Injections, Subcutaneous; Mice; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Receptors, Dopamine D1 | 1992 |
Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzopyrans; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Locomotion; Macaca; Parkinson Disease; Receptors, Dopamine D1 | 1996 |
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzopyrans; Callithrix; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Quinolones; Receptors, Dopamine D1; Thiophenes | 1999 |
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Autoradiography; Binding Sites; Carrier Proteins; Caudate Nucleus; Denervation; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Imidazoles; In Situ Hybridization; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Neurotensin; Piperidines; Putamen; Receptors, Dopamine; Receptors, Neurotensin; RNA, Messenger; Substantia Nigra | 1999 |
Endogenous dopaminergic tone and dopamine agonist action.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Benzopyrans; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Levodopa; Locomotion; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2000 |
The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzazepines; Benzopyrans; Callithrix; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Female; Male; Motor Activity; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2002 |
[Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Corpus Striatum; Disease Models, Animal; Hippocampus; Male; MPTP Poisoning; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1 | 2010 |
[A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Brain; Dopamine Plasma Membrane Transport Proteins; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders | 2011 |
[Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Antiparkinson Agents; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Neurotoxins; Parkinson Disease, Secondary | 2011 |
[Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Cognition; Drug Administration Schedule; Male; Neurotoxins; Parkinson Disease, Secondary; Rats; Time Factors | 2012 |
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Behavior, Animal; Cell Survival; Cells, Cultured; Dopaminergic Neurons; Epoxide Hydrolases; Lauric Acids; Male; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Paraquat; Parkinsonian Disorders; Rotarod Performance Test; Solubility; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 2015 |